These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2475690)

  • 61. Verapamil in antihypertensive treatment of patients on renal replacement therapy--clinical implications and pharmacokinetics.
    Beyerlein C; Csaszar G; Hollmann M; Schumacher A
    Eur J Clin Pharmacol; 1990; 39 Suppl 1():S35-7. PubMed ID: 2261942
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of betaxolol with verapamil in hypertensive patients: discrepancy between office and ambulatory blood pressures.
    Waeber G; Beck G; Waeber B; Bidiville J; Nussberger J; Brunner HR
    J Hypertens; 1988 Mar; 6(3):239-45. PubMed ID: 3283227
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning.
    Smith DH; Neutel JM; Weber MA
    Am J Hypertens; 2001 Jan; 14(1):14-9. PubMed ID: 11206672
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Serum ionized calcium--a predictor of therapeutic response to slow calcium channel blockade in essential hypertension.
    Midtbø K; Hals O
    Angiology; 1987 Nov; 38(11):841-6. PubMed ID: 3688552
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Multiple dose comparison of a whole 240 mg verapamil sustained-release tablet with two half tablets.
    Moreland TA; McMurdo ME; McEwen J
    Biopharm Drug Dispos; 1989; 10(3):311-9. PubMed ID: 2720134
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of verapamil and captopril in elderly hypertensive subjects: results of a randomized, double-blind, crossover study.
    Bursztyn M; Ghanem J; Kobrin I; Fidel J; Ben-Ishay D
    J Cardiovasc Pharmacol; 1993 Jan; 21(1):84-8. PubMed ID: 7678684
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of moexipril, a new ACE inhibitor, to verapamil-SR as add-on therapy to low dose hydrochlorothiazide in hypertensive patients.
    Chrysant SG; Fox AA; Stimpel M
    Am J Hypertens; 1995 Apr; 8(4 Pt 1):418-21. PubMed ID: 7619356
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sustained-release verapamil as a first-step drug in the treatment of mild to moderate hypertension.
    Karcier SM; Orbay B; Ozder AB; Gürses N; Aytekin S; Satar S; Oztürk M; Demiroğlu C
    J Int Med Res; 1989; 17(3):268-76. PubMed ID: 2767329
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
    Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS
    Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Population analyses of sustained-release verapamil in patients: effects of sex, race, and smoking.
    Kang D; Verotta D; Krecic-Shepard ME; Modi NB; Gupta SK; Schwartz JB
    Clin Pharmacol Ther; 2003 Jan; 73(1):31-40. PubMed ID: 12545141
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The combination of prazosin and verapamil in the treatment of essential hypertension.
    Elliott HL; Meredith PA; Campbell L; Reid JL
    Clin Pharmacol Ther; 1988 May; 43(5):554-60. PubMed ID: 3284690
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
    Joglekar SJ; Jaguste V; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [A comparison of the effects of verapamil and nifedipine on the quality of life].
    Palmer A; Fletcher A; Hamilton G; Muriss S; Bulpitt C
    Wien Med Wochenschr; 1991; 141(18-19):424-8. PubMed ID: 1776257
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of sustained-release Verapamil on the morning systemic arterial pressure surge during daily activity in patients with systemic hypertension.
    Rosito GA; Gebara OC; McKenna CA; Solomon HS; Muller JE; Tofler GH
    Am J Cardiol; 1997 May; 79(9):1252-5. PubMed ID: 9164897
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study).
    Brunner M; Cooper-DeHoff RM; Gong Y; Karnes JH; Langaee TY; Pepine CJ; Johnson JA;
    Am J Cardiol; 2007 Jun; 99(11):1549-54. PubMed ID: 17531579
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
    Bangalore S; Messerli FH; Franklin SS; Mancia G; Champion A; Pepine CJ
    Eur Heart J; 2009 Jun; 30(11):1395-401. PubMed ID: 19351690
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [The effects of slow-release verapamil in relation to plasma concentration in aged hypertensives. A study with continuous monitoring of arterial pressure and electrocardiogram].
    Canonico V; Bonaduce D; De Caprio L; Nicolino A; Forgione L; Petretta M; Rengo F
    G Ital Cardiol; 1990 Oct; 20(10):924-32. PubMed ID: 2090531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.